FDAnews
www.fdanews.com/articles/188791-hologics-bordetella-assay-earns-ce-mark
Hologic logo

Hologic’s Bordetella Assay Earns CE Mark

October 12, 2018

Hologic received the CE Mark for its Panther Fusion Bordetella assay, expanding the menu of the molecular testing device.

The real-time PCR assay can detect and differentiate between B. pertussis and B. parapertussis from samples collected from the patient’s nasopharynx.

Because the assay can differentiate between the two bacteria, which are known to cause whooping cough, it enables physicians to prescribe the right antibiotic for the patient.

View today's stories